Delphia (Usa) Inc. Eli Lilly & CO Transaction History

Delphia (Usa) Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $36,827 - $49,242	-105 Reduced 7.37%	1,319 $618,000
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $22,054 - $25,902	71 Added 5.25%	1,424 $489,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $100,645 - $117,271	313 Added 30.1%	1,353 $494,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $594,738 - $677,767	-2,006 Reduced 65.86%	1,040 $336,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $70,797 - $83,126	254 Added 9.1%	3,046 $988,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $203,006 - $252,285	865 Added 44.89%	2,792 $800,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $433,285 - $537,710	1,927 New	1,927 $532,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.